Hematologic malignancies: an opportunity to fill a gap in cancer surveillance

[1]  A. Freedman,et al.  Follicular lymphoma: 2011 update on diagnosis and management , 2011, American journal of hematology.

[2]  C. Cogle,et al.  Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries. , 2011, Blood.

[3]  H. Kantarjian,et al.  Hematologic malignancies: where do we stand in 2011? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Williamson,et al.  How does the media profile of cancer compare with prevalence? , 2011, Annals of the Royal College of Surgeons of England.

[5]  J. Gribben Chronic lymphocytic leukemia: planning for an aging population , 2010, Expert review of anticancer therapy.

[6]  J. Gribben How I treat CLL up front. , 2010, Blood.

[7]  D. McClish,et al.  Impact of automated data collection from urology offices: improving incidence and treatment reporting in urologic cancers. , 2010, Journal of registry management.

[8]  S. Gibson,et al.  High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: a population-based Canadian cohort. , 2009, Leukemia research.

[9]  J. C. Barros Leucemia linfocítica crônica & visão geral , 2009 .

[10]  K. Maddocks,et al.  Update in the management of chronic lymphocytic leukemia , 2009, Journal of hematology & oncology.

[11]  S. Schappert,et al.  Use of medical care for chronic conditions. , 2009, Health affairs.

[12]  Xiaomei Ma,et al.  Prevalence of polycythemia vera and essential thrombocythemia , 2008, American journal of hematology.

[13]  D. Ransohoff,et al.  Evaluation of Claims, Medical Records, and Self-report for Measuring Fecal Occult Blood Testing among Medicare Enrollees in Fee for Service , 2008, Cancer Epidemiology Biomarkers & Prevention.

[14]  M. Björkholm,et al.  Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003 , 2007, International journal of cancer.

[15]  J. Aisner Overview of the changing paradigm in cancer treatment: oral chemotherapy. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[16]  S. Schneeweiss,et al.  Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data , 2007, Cancer Causes & Control.

[17]  Suanna S Bruinooge,et al.  Future supply and demand for oncologists : challenges to assuring access to oncology services. , 2007, Journal of oncology practice.

[18]  L. Clegg,et al.  Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Bergh,et al.  Reducing the global breast cancer burden: the importance of patterns of care research. , 2005, Clinical breast cancer.

[20]  D. Penson Variations in prostate cancer patterns of care: is it the quality of care or the quality of the data? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  D. West,et al.  Cancer Surveillance Research: a Vital Subdiscipline of Cancer Epidemiology , 2005, Cancer Causes & Control.

[22]  H. Weir,et al.  Using Data to Motivate Action: The Need for High Quality, an Effective Presentation, and an Action Context for Decision-making , 2005, Cancer Causes & Control.

[23]  D. McClish,et al.  The Added Value of Claims for Cancer Surveillance: Results of Varying Case Definitions , 2005, Medical care.

[24]  L. Clegg,et al.  Patterns of care in a population‐based random sample of patients diagnosed with non‐Hodgkin's lymphoma , 2005, Hematological oncology.

[25]  James J. Beaumont,et al.  Factors associated with time to availability for cases reported to population-based cancer registries⋆ , 2004, Cancer Causes & Control.

[26]  H. Koh,et al.  Using public health data systems to understand and eliminate cancer disparities , 2005, Cancer Causes & Control.

[27]  C. Pashos,et al.  The clinical and epidemiological burden of chronic lymphocytic leukaemia. , 2004, European journal of cancer care.

[28]  C. Pashos,et al.  Clinical and epidemiologic burden of chronic myelogenous leukemia , 2004, Expert review of anticancer therapy.

[29]  E. Holly,et al.  Expert Review of Non-Hodgkin’s Lymphomas in a Population-Based Cancer Registry , 2004, Cancer Epidemiology Biomarkers & Prevention.

[30]  Hannah K. Weir,et al.  Building the infrastructure for nationwide cancer surveillance and control – a comparison between The National Program of Cancer Registries (NPCR) and The Surveillance, Epidemiology, and End Results (SEER) Program (United States) , 2003, Cancer Causes & Control.

[31]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[32]  A. Potosky,et al.  Patterns of care for the treatment of bladder cancer. , 2003, The Journal of urology.

[33]  M. Løchen,et al.  Haematological malignancies in a general population, based on information collected from a population study, hospital records, and the Cancer Registry of Norway , 2002, European journal of haematology.

[34]  Beth A Virnig,et al.  Utility of the SEER-Medicare Data to Identify Chemotherapy Use , 2002, Medical care.

[35]  L. Clegg,et al.  Adjuvant therapy for breast cancer: practice patterns of community physicians. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  S. Schichman,et al.  Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data , 2001, Cancer.

[37]  M. Åström,et al.  Adjustment of Incidence Rates after an Estimate of Completeness and Accuracy in Registration of Acute Leukemias in a Swedish Population , 2001, Leukemia & lymphoma.

[38]  Joseph V. Simone,et al.  Enhancing Data Systems to Improve the Quality of Cancer Care , 2000 .

[39]  S. D. Risley,et al.  The American Medical Association , 1893, The Hospital.